GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Xinbang Pharmaceutical Co Ltd (SZSE:002390) » Definitions » Issuance of Debt

Guizhou Xinbang Pharmaceutical Co (SZSE:002390) Issuance of Debt : ¥804 Mil (TTM As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Guizhou Xinbang Pharmaceutical Co Issuance of Debt?

Guizhou Xinbang Pharmaceutical Co's Issuance of Debt for the three months ended in Mar. 2025 was ¥153 Mil.

Guizhou Xinbang Pharmaceutical Co's Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2025 was ¥804 Mil.


Guizhou Xinbang Pharmaceutical Co Issuance of Debt Historical Data

The historical data trend for Guizhou Xinbang Pharmaceutical Co's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhou Xinbang Pharmaceutical Co Issuance of Debt Chart

Guizhou Xinbang Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,533.50 2,112.00 1,985.37 1,210.50 895.10

Guizhou Xinbang Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 244.10 280.00 58.90 312.10 153.00

Guizhou Xinbang Pharmaceutical Co Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥804 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guizhou Xinbang Pharmaceutical Co Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Guizhou Xinbang Pharmaceutical Co's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Guizhou Xinbang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
6th Floor, Kekai 1st Court, Intersection of Aerospace Avenue and Xintian Avenue, Wudang District, Guiyang, CHN
Guizhou Xinbang Pharmaceutical Co Ltd is a China-based pharmaceutical company. The company is engaged in providing medical services and pharmaceutical distribution. The scope of business also covers the cultivation of Chinese herbal medicines, production of Chinese herbal medicines and Chinese patent medicines, research and development, production and sales of biological drugs, and other fields.
Executives
An Ji Director
Gao Wen Lin Executives
Lu Ya Fang Executives
Xu Qi Directors, executives
An Huai Lve Director
Ma Cheng Director
Zhang Jie Qing Directors, executives
Kong Ling Zhong Directors, executives
Liu Xiao Yang Executives
Xiao Ya Yun Executives
Yang Pei Executives
Zhang Guan Fu Director
Chen Chuan Directors, executives
He Wen Jun Supervisors
Lv Yu Tao Director

Guizhou Xinbang Pharmaceutical Co Headlines

No Headlines